Cargando…

Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics

Although the kidney has capacity to repair after mild injury, ongoing or severe damage results in scarring (fibrosis) and an associated progressive loss of kidney function. However, despite its universal significance, evidence highlights a population based heterogeneity in the trajectory of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hewitson, Timothy D., Holt, Stephen G., Smith, Edward R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550676/
https://www.ncbi.nlm.nih.gov/pubmed/28848437
http://dx.doi.org/10.3389/fphar.2017.00520
_version_ 1783256160637288448
author Hewitson, Timothy D.
Holt, Stephen G.
Smith, Edward R.
author_facet Hewitson, Timothy D.
Holt, Stephen G.
Smith, Edward R.
author_sort Hewitson, Timothy D.
collection PubMed
description Although the kidney has capacity to repair after mild injury, ongoing or severe damage results in scarring (fibrosis) and an associated progressive loss of kidney function. However, despite its universal significance, evidence highlights a population based heterogeneity in the trajectory of chronic kidney disease (CKD) in these patients. To explain the heterogeneity of the CKD phenotype requires an understanding of the relevant risk factors for fibrosis. These factors include both the extrinsic nature of injury, and intrinsic factors such as age, gender, genetics, and perpetual activation of fibroblasts through priming. In many cases an additional level of regulation is provided by epigenetic mechanisms which integrate the various pro-fibrotic and anti-fibrotic triggers in fibrogenesis. In this review we therefore examine the various molecular and structural changes of fibrosis, and how they are influenced by extrinsic and intrinsic factors. Our aim is to provide a unifying hypothesis to help explain the transition from acute to CKD.
format Online
Article
Text
id pubmed-5550676
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55506762017-08-28 Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics Hewitson, Timothy D. Holt, Stephen G. Smith, Edward R. Front Pharmacol Pharmacology Although the kidney has capacity to repair after mild injury, ongoing or severe damage results in scarring (fibrosis) and an associated progressive loss of kidney function. However, despite its universal significance, evidence highlights a population based heterogeneity in the trajectory of chronic kidney disease (CKD) in these patients. To explain the heterogeneity of the CKD phenotype requires an understanding of the relevant risk factors for fibrosis. These factors include both the extrinsic nature of injury, and intrinsic factors such as age, gender, genetics, and perpetual activation of fibroblasts through priming. In many cases an additional level of regulation is provided by epigenetic mechanisms which integrate the various pro-fibrotic and anti-fibrotic triggers in fibrogenesis. In this review we therefore examine the various molecular and structural changes of fibrosis, and how they are influenced by extrinsic and intrinsic factors. Our aim is to provide a unifying hypothesis to help explain the transition from acute to CKD. Frontiers Media S.A. 2017-08-08 /pmc/articles/PMC5550676/ /pubmed/28848437 http://dx.doi.org/10.3389/fphar.2017.00520 Text en Copyright © 2017 Hewitson, Holt and Smith. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hewitson, Timothy D.
Holt, Stephen G.
Smith, Edward R.
Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title_full Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title_fullStr Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title_full_unstemmed Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title_short Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
title_sort progression of tubulointerstitial fibrosis and the chronic kidney disease phenotype – role of risk factors and epigenetics
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550676/
https://www.ncbi.nlm.nih.gov/pubmed/28848437
http://dx.doi.org/10.3389/fphar.2017.00520
work_keys_str_mv AT hewitsontimothyd progressionoftubulointerstitialfibrosisandthechronickidneydiseasephenotyperoleofriskfactorsandepigenetics
AT holtstepheng progressionoftubulointerstitialfibrosisandthechronickidneydiseasephenotyperoleofriskfactorsandepigenetics
AT smithedwardr progressionoftubulointerstitialfibrosisandthechronickidneydiseasephenotyperoleofriskfactorsandepigenetics